with a set of efficient DNA tests

New oncogenetic tests

Published23/05/2012

Asper Oncogenetics portfolio has been upgraded with new tests for the risk assessment and diagnostics of colorectal cancer. Colorectal cancer tests are presented at an introductory offer, with 10% discount of the standard prices. The offer is valid until the end of 2012.